IR

Highlights of business performance

<Consolidated Basis>

Net sales


(Unit:Million Yen)
  FY2007 FY2008 FY2009 FY2010 FY2011(1H) FY2011(Plan)
Net sales 184,309 147,003 134,134 144,882 66,138 141,000


Operating income/Ordinary income/Net income

(Unit:¥ Million %)
  FY2007 FY2008 FY2009 FY2010 FY2011(1H) FY2011(Plan)
Operating income 8,269 -4,891 -5,482 6,149 1,300 5,000
Ordinary income 4,481 -7,716 -6,048 4,972 369 3,200
Net income 1,776 -15,773 -18,950 -922 -1,261 500
Ordinary income:Income before income taxes and extraordinary items


Total assets/Total liabilities/Equity ratio

(Unit:¥ Million %)
  2008.3 2009.3 2010.3 2011.3 2011.9
Total assets 173,529 147,768 131,908 132,384 126,819
Total liabilities 95,447 89,950 94,147 98,863 97,220
Equity ratio 44.7 38.8 28.2 25.1 23.1


Per share amounts

(Unit:¥)
  FY2007 FY2008 FY2009 FY2010 FY2011(1H)
Net income per share 14.62 -129.85 -156.05 -7.60 -10.40
Dividends per share 14.00 10.00 0.00 6.00 0.00


Net income to shareholders' equity(ROE)/Ordinary income to total assets(ROA)


(Unit:%)
  FY2006 FY2007 FY2008 FY2009 FY2010
Net income to shareholders' equity(ROE) 9.43 2.22 -23.38 -40.09 -2.62
Ordinary income to total assets(ROA) 6.96 2.44 -4.80 -4.33 3.76


Capital expenditures/Depreciation expenses


(Unit:¥ Million)
  FY2007 FY2008 FY2009 FY2010 FY2011(1H) FY2011(Plan)
Capital expenditures 7,875 12,283 4,978 10,595 5,921 14,000
Depreciation expenses 14,199 12,263 9,899 8,308 4,121 9,000
Capital expenditure in FY08 includes purchase option exercised at expiry on capital leases for the purchase price of ¥3 billion.


Research and development expenses

(Unit:¥ Million)
  FY2007 FY2008 FY2009 FY2010 FY2011(1H)
Research and development expenses 13,673 13,468 11,116 11,640 5,967


The number of Sanken Group (SG) associates

(Associates)
  2008.3 2009.3 2010.3 2011.3 2011.9
Number of SG associates 10,379 10,063 9,986 9,981 10,030
Top of page